20,000
Participants
Start Date
November 8, 2022
Primary Completion Date
November 30, 2027
Study Completion Date
November 30, 2027
EBV biomarker testing
"15 ml of blood will be collected for EBV EA IgA serology and plasma EBV DNA testing by a trained nursing/phlebotomy staff. If the initial plasma EBV DNA test is positive, a second blood draw will be performed for repeat plasma EBV DNA testing.~Additionally, 2-3 ml of saliva will be collected for EBV strain identification, however, this information is not used for risk stratification in this study.~Demographic characteristics, clinical history and symptoms will be collected through a questionnaire."
RECRUITING
National University Hospital, Singapore
RECRUITING
National University Polyclinics, Singapore
Collaborators (1)
National Medical Research Council (NMRC), Singapore
OTHER_GOV
Genome Institute of Singapore
OTHER
Pathnova Laboratories, Singapore
UNKNOWN
National University of Singapore
OTHER
National University Hospital, Singapore
OTHER